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Abstract: Pharmaceuticals recently have acquired a big importance because of its growing detection in wastewater. The 
propionic acid derivatives, such as ibuprofen, are among the most commonly anti-inflammatories used by population. For 
this reason it is necessary to develop a friendly separation technique with environment, like the Supported Liquid 
Membranes (SLM). In this work, SLM have been prepared in order to recover ibuprofen from aqueous solutions. Two 
different organic phases were evaluated (dodecane and Parleam 4), as well as trioctylamine as carrier, and Abil EM 90 
as surfactant in the preparation of SLM. The SLM prepared was tested in the IBP transfer process through the 
membrane, from feed phase to stripping phase. The results showed that it is possible to recover almost 98% of IBP, this 
using the SLM and a phosphate buffer solution of pH 7 like stripping phase. 
Keywords: Ibuprofen, Supported liquid membranes, Permeability, Molar flux, Wastewater. 
INTRODUCTION 
Pharmaceuticals recently have acquired a big 
importance because of its growing detection in 
wastewater. The use of prescribed or over counter 
drugs is estimated worldwide in thousands of metric 
tons per year [1, 2]. The main sources of emissions of 
these compounds are: domestic, hospital, livestock 
(fecal and urinary excretions both from humans and 
animals after drug use) and industrial (accidental 
spillages) effluents [3]. They represent a grave problem 
due to their bioaccumulation may occur and provoking 
different adverse effects on organisms and 
environmental in spite of the low concentration at which 
they are found (mg.L-1 or ng.L-1)[2, 4-10]. 
There are several techniques utilized to wastewater 
treatment which are: bioremediation, physicochemical 
treatments such as activated sludge, coagulation, 
volatilization, adsorption (activated carbon), 
sedimentation and filtration, and advanced oxidation 
process (ozonation, UV irradiation, Fenton oxidation, 
photocatalysis and sonolysis). However, these 
methods are little effectives for the removal of organic 
compounds, such as drugs [1, 3, 4, 7].  
The drugs most commonly found in wastewater are: 
anti-inflammatories, analgesics, antibiotics, 
antihypertensives, hormones, lipidic regulators, β- 
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blockers, anxiolytics, anticonvulsants, anti-ulcer agents, 
diuretics, antidiabetics and bronchodilators [2, 4-7, 9, 
11]. The propionic acid derivatives, such as ibuprofen, 
are among the most commonly used anti-
inflammatories by population [3, 9, 12]. Ibuprofen has 
been detected in sewage treatment plants effluents and 
surface water at concentrations ranging from 674 – 
85000 ng.L-1 in parts of USA, Canada and Europe [9, 
13-17]. This drug does not represent any problem at 
acute exposure, but at long-term exposure it can be 
toxic both to humans and to animals [1].Toxic effects 
have been reported to bacteria, algae and daphnia 
magna, damaging the population growth rate and 
reproduction of this latter [18-20]. Since ibuprofen is a 
drug of wide human consumption, it can be found in 
sewage, its recovery from these effluents is very 
important. 
There are reports about the ibuprofen elimination by 
oxidation techniques as ultrasound treatment [21] or 
with photo-Fenton oxidation process [22], and photo-
transformation with low pressure mercury lamps [23] or 
using thermally activated persulfate (TAP) [24]. In the 
case of IBP recovery from aqueous solutions, one of 
the methods reported is by adsorption with activated 
carbon produced from wastes of Agave Sisalana [25], 
or using emulsion liquid membranes [10]. 
The supported liquid membranes (SLM) offer a 
useful alternative to separation and recovery of 
different compounds present in wastewater. They are a 
kind of non-dispersive liquid membranes where the 
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organic phase is embedded in pores of a polymer 
support. The organic phase consists of a diluent, a 
carrier and some times of a modifier. This modifier is 
added in order to favor the species extraction and 
avoiding the third phase formation [26, 27]. The 
advantages to use this technique (SLM) are that the 
extraction and stripping of the species is performed in 
one step, the volume of organic components is very 
small thus the pollution is very low, it is easy to scale-
up, etc [28, 29]. The applications of SLMs include the 
recovery of metals and ions from effluents (Ni(II), 
Cu(II), Zn(II), Hg(II), Cd(II), Cr (VI), Pt(IV), Pd (II)) [29-
34], of organic acids like citric acid [35], of drugs 
(cephalexin, macrolides, acetaminophen) [36-38], and 
as concentration method [39]. 
In this study a methodology for ibuprofen recovery 
from aqueous solutions by supported liquid membranes 
was developed. Dodecane and Parleam 4 were used 
like organic phases, trioctylamine (TOA) as carrier and 
Abil EM 90 as surfactant. The influence of different 
parameters such as, the surfactant and extractant 
concentrations, the nature of stripping solution, time 
transfer and surfactant presence have been analyzed. 
THEORETICAL 
The supported liquid membranes (SLM) consist of a 
microporous filter (polymer support) and an organic 
phase which is embedded in pores of this filter. The 
organic phase consists of a diluent, a carrier and 
sometimes of a modifier. 
The mass transfer process through supported liquid 
membrane can divided in several steps (see Figure 1) 
[27, 40]: 
1. IBP diffusion in the non-stirred boundary layer 
(feed phase-membrane interface, zone a). 
2. Formation of IBP-Extractant (E) complex at the 
feed phase-SLM interface, zone b. 
3. Diffusion of complex formed, IBP-Extractant 
through SLM, zone c. 
4. IBP stripping from IBP-Extractant complex at the 
SLM-stripping phase interface, zone d. 
5. IBP diffusion in the non-stirred boundary layer 
(membrane-stripping phase interface, zone e). 
 
Figure 1: Graphical representation of IBP transfer through 
SLM. 
If it considered that chemical reactions between IBP 
and extractant are fast in the feed-membrane and 
membrane-strip interfaces, it is possible to say that the 
flux J is determined by the IBP diffusion in the limit 
zones of diffusion and in SLM. The IBP mass transport 








IBP[ ]i,s " IBP[ ]tot ,s{ }  
where 
Ja and Je (mol.cm-2.min-1) are the Molar Fluxes of 
IBP in the diffusion boundary layer of feed phase-
membrane and membrane-stripping phase interfaces, 
respectively. 
δa, δe are the thickness of the diffusion boundary 
layer of feed phase-membrane and membrane-
stripping phase interfaces, respectively. 
DIBP is the IBP diffusion coefficient in feed phase-
membrane and membrane-stripping phase interfaces. 
[IBP]tot, f total concentration of IBP in feed phase. 
[IBP]i, fa IBP concentration in feed phase-membrane 
interface. 
[IBP]i, s IBP concentration in stripping phase-
membrane interface. 
[IBP]tot, f total concentration of IBP in stripping phase. 
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The flux can be defined by permeability. 
Permeability measures the quantity of transported 
solute through a specific area from the membrane 
surface into a given unit time [41]. This parameter can 
be determined experimentally by the equation (1):  
 
ln IBP[ ]tIBP[ ]t,o = !P
Q
V t  
          (1) 
where 
P = SLM permeability (cm.min-1) 
[IBP]t y [IBP]t,0 = IBP concentration at time t and at 
time t = 0, respectively. 
Q = SLM area (cm2). 
V = volume of feed phase (cm3). 
T = time (minutes). 
Equation (1) has the form of straight line with –P as 
the slope. The variation of In([IBP]t/[IBP]t,0) as a 
function of (Q/V)t allows the determination of straight 
line slope and thus, of Permeability. 
The IBP Flux through SLM is obtained by equation 
(2), in which permeability is related with the molar flux 
and initial concentration of drug in the feed phase: 
P = JIBP[ ]t,o            (2) 
where: 
J = molar flux of drug (mol.cm-2.min-1). 
[IBP]t,0= initial concentration of IBP in feed phase 
(mol.cm-3). 
MATERIALS AND METHODS 
The ibuprofen structure is showed in Figure 2. 
Dodecane (Sigma Aldrich) was used like organic 
solvent, trioctylamine (TOA) (Sigma Aldrich) as a 
carrier to improve the transfer rate of IBP from the feed 
phase to stripping phase and Abil EM 90® (modified 
polyether-polysiloxane) (Evonik Industries) as 
surfactant. 
 
Figure 2: Ibuprofen (IBP) chemical structure. 
The feed phase was composed by IBP dissolved in 
aqueous solution at pH 2 and the strip phase by 
phosphate buffer pH 7 or carbonate buffer pH 7. 
The support used for the SLM preparation was a 
microfiltration filter (Millipore) of polyvinylidene 
difluoride (hydrophobic PVDF) with 47 mm of diameter, 
0.22 µm of pore size, 125 µm of thickness and 75% of 
porosity. 
In order to prepare the supported liquid membrane 
(SLM), the support (hydrophobic PVDF, polyvinylidene 
difluoride) was submerged in an organic solution 
containing the carrier (TOA, 1% w/V and 2% w/V) or 
the mix of the carrier + surfactant (Abil EM 90, 0.5% 
w/V and 1% w/V), diluted in dodecane or Parleam 4. 
The support was impregnated during 2 hours and then 
it was removed from the organic solution, allowing to 
drain off for 30 minutes. The device used in the SLM 
experiments is shown in Figure 3. It consists in two 
cells (feed cell and stripping cell) communicated with a 
circular window. The SLM is placed on the circular 
window, between the cells 1 and 2, and the system is 
assembled. The feed and stripping solutions are added 
to cells 1 and 2, respectively. The cells are then 
covered and the system is stirred. Aliquots were taken 
from both cells at several different times and, finally the 
ibuprofen concentration was quantified by UV/Visible 
spectrometry (Varian Cary 50 Scan) at 222 nm. 
 
Figure 3: Schematic representation of equipment for IBP 
transfer by supported liquid membranes. 
RESULTS AND DISCUSSION 
The efficiency of IBP separation by the SLM was 
evaluated considering different parameters as the 
nature of stripping solution, the carrier concentration, 
the stirring rate and the surfactant presence. For each 
condition the curves of the variation of IBP 
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concentration as a function of time for the feed solution 
as well as the stripping solution were obtained. 
Razo-Lazcano et al. [10] have been pointed out that 
the IBP distribution between an aqueous phase and an 
organic phase (dodecane or Parleam 4) is carried out 
by a simple partition mechanism. At low pH (2), high 
IBP extraction is reached, while at pH higher than 6.5 
the IBP concentration in the organic phase is null. 
Then, dodecane and Parleam 4 were used like organic 
phases in the SLM preparation. However, because 
their viscosity values (1.34 x 10-3 Pa.s and 2.4521 x 10-3 
Pa.s, respectively), Parleam 4 is able to impregnate 
better the membrane and, therefore, able to increase 
the stability of the SLM. Trioctylamine was used as 
carrier because its ability to extract organic acids [10, 
42, 43]. On the other hand, the use of surfactant 
decrease the interfacial tension between the interface 
of aqueous-MLS phase, allowing a better wetting of the 
membrane and thus a greater solute flux [29, 31]. So, 
Abil EM 90 was chosen as surfactant, which is a non 
ionic surfactant with applications in cosmetic industry. 
Effect of Strippant Nature on SLM Efficiency 
The study of IBP transfer from a feed phase to a 
stripping phase across a SLM, was performed 
considering the acid-base properties of IBP as well as 
the conditions of feed phase and stripping phase. The 
IBP is extracted by dodecane or Parleam 4 in its 
neutral form, at the feed phase conditions (pH 2). In 
this way the IBP is transferred from the feed phase to 
the SLM. To make the transfer from MLS to the 
stripping phase, it is necessary to use a solution able to 
yield the IBP in its ionic form. So, NaOH was evaluated 
like stripping phase at two different concentrations (1 x 
10-4mol.L-1 and 1 x 10-2 mol.L-1). The results obtained 
show that recovery percentages are 30% and 50% 
respectively, after 3 hours of experiment. For this 
reason, we decided to use phosphate and carbonate 
buffers solutions at pH 7 as strippants to increase the 
system efficiency and to better regulate the pH 
changes. Figure 4 shows the [IBP]t/[IBP]o variation as a 
function of time for both stripping solutions. 
It is possible to see that the [IBP]t/[IBP]o proportion 
decreases with the time in the feed solution while the 
relation ([IBP]t/[IBP]o) increases in the stripping phase. 
Therefore, there is an IBP transfer from the feed 
solution to the stripping solution across the SLM.  
On the other hand, as it mentioned above, we can 
compare the SLM efficiency by the help of 
Permeability. The variation of ln [IBP]t/[IBP]t,0 as a 
function of t(Q/V)is represented in Figure 5. It is 
possible to obtain the Permeability value (P) from the 
slope of the straight line. 
From Figure 5, it is possible to observe that the 
Permeability are quite similar for both phosphate and 
carbonate buffers (0.1005 and 0.1025 cm.min-1, 
respectively). Thus, the IBP transfer has a similar 
behavior for the two stripping solutions. Thus, the 
ibuprofen transfer from the feed phase to the stripping 
phase is about 60% for both conditions after 3 hours; 
however, using phosphate buffer at pH 7, the drug 
transfer to membrane and from this one to stripping 
phase is slightly greater at less time. In addition, the 
buffer capacity of phosphates (H2PO4-/HPO4-2) is 
bigger at pH close to 7. For these reasons, phosphate 
buffer was chosen like stripping phase. 
Effect of Stirring Rate on SLM Efficiency 
The stirring rate applied to feed phase was varied in 
order to observe the effect on the SLM transfer 
efficiency keeping the stirring rate of stripping phase as 
 
Figure 4: IBP transfer through the SLM. Feed phase: [IBP] = 50 mg.L-1 dissolved in solution at pH 2. Strip phase: a) Phosphate 
buffer at pH 7 ( feed, strip), b) Carbonate buffer at pH 7 ( feed, strip). SLM: hydrophobic polyvinylidene difluoride 
support (PVDF) impregnated with TOA 1% w/V dissolved in dodecane. Stirring rate for both cells: 1000 rpm; transfer time: 3 
hours. 
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constant. Table 1 shows the Permeability as well as the 
Molar Flux obtained after 3 hours of contact between 
the SLM and the phases 
The P and J values are quite similar for all the 
conditions. But if Figure 6 is analyzed, it is possible to 
observe some differences between the [IBP]t/[IBP]o 
curves as a function of time. When the stirring rate is 
1000 rpm into the feed phase, the IBP transfer is 
slightly faster than the other stirring rates. Other 
difference is that the point where the [IBP] in the feed 
phase crosses the line of the [IBP] in the stripping 
phase is close to 0.5 for the [IBP]t/[IBP]o rate. This 
means that the IBP does not accumulate on the SLM 
and all the ibuprofen is transferred to the stripping 
phase. 
Effect of TOA Concentration on SLM Efficiency 
The influence of TOA concentration in the mass 
transfer process of IBP through the SLM was evaluated 
for 1% w/V and 2% w/V of TOA, after 10 hours of 
transfer time. The results obtained are shown in Figure 
7, from which the Permeability value was deduced.  
 
Figure 6: IBP transfer by SLM. Stir rate:  Feed 500rpm,  
Strip 1000 rpm;  Feed 800 rpm, Strip1000 rpm  ; Feed 
1000 rpm,  Strip 1000 rpm. Feed: [IBP] = 50 mg.L-1 
dissolved in solution at pH 2, Strip: phosphate buffer at pH 7, 
SLM: hydrophobic polyvinylidene difluoride support (PVDF) 
impregnated with TOA 1% w/V dissolved in dodecane.  
For a TOA concentration of 1% w/V a permeability 
value of 0.085 cm.min-1 was obtained and 0.1197 
cm.min-1 for 2% w/V of TOA. That is, the SLM 
impregnated with 2% w/V of TOA allows a more IBP 
transfer through it with a flux molar value of 3.1 x 10-8 
mol.cm-2.mol-1. 
 
Figure 5: ln ([IBP]t / [IBP]t,0) variation as a function of t(Q/V) during the IBP transfer through the SLM. Feed phase: [IBP] = 50 
mg.L-1 dissolved in solution at pH 2. Stripping phase: a) Phosphate buffer at pH 7, b) Carbonate buffer at pH 7 SLM: 
hydrophobic polyvinylidene difluoride support (PVDF) impregnated with TOA 1% w/V dissolved in dodecane. Stirring rate for 
both cells: 1000 rpm. 
Table 1: Permeability and Molar Flux of IBP. Feed Phase: [IBP] = 50 mg.L-1 Dissolved in Solution at pH 2, Stripping 
Phase: Phosphate Buffer at pH 7, SLM: Hydrophobic Polyvinylidene Difluoride Support (PVDF) Impregnated 









500 1000 3 0.1044 2.5 x 10-8 
800 1000 3 0.0963 2.3 x 10-8 
1000 1000 3 0.1005 2.4 x 10-8 
 
26    International Journal of Membrane Science and Technology, 2015, Vol. 2 Razo-Lazcano et al. 
However, this increase of TOA concentration in the 
SLM provokes that IBP stays in more quantity on the 
membrane because of the complex formed (IBP-TOA) 
is more stable at higher TOA concentrations. Figure 8 
reveals this phenomenon; a higher Permeability is 
obtained when a bigger concentration of TOA is used, 
but some IBP mass remains into the SLM. 
It is important to remark that the 98% of IBP was 
transferred to stripping phase after 10 hours, and that 
the SLM was stable during all the experiment. No 
droplets of organic phase were observed in any of the 
phases. On the other hand, the PVDF is a polymer that 
allows re-using the membrane many times. 
 
Figure 8: IBP transfer trough the SLM. TOA concentration: 1 
% w/V  Feed,  Strip; 2 % w/V Feed  Strip  Feed: 
[IBP] = 50 mg.L-1 dissolved in solution at pH 2, Strip: 
phosphate buffer at pH 7, SLM: hydrophobic polyvinylidene 
difluoride support (PVDF) impregnated with TOA dissolved in 
dodecane. Stirring rate 1000 rpm in the both cells. 
Surfactant Effect on SLM Efficiency 
In order to improve the IBP flux through the 
supported liquid membrane, a surfactant, Abil EM 90, 
was added to organic phase with which the membrane 
was impregnated. The surfactant is able to decrease 
the interfacial tension, between the impregnated phase 
and the aqueous phase and allowing a better wetting of 
the membrane; hence a greater solute flux [29, 31]. 
Table 2 shows the SLM efficiency with respect the 
IBP recovery through the Permeability and Molar Flux 
at different surfactant concentrations. 
The Permeability and Molar Flux values increase 
when the surfactant concentration increases. According 
to these values, the membrane impregnated with 1% 
w/V Abil EM 90 + 1% TOA + Parleam 4 has a 
permeability of 0.1939 cm.min-1; then, is more 
permeable to ibuprofen. For this reason, it is possible 
to say that the increase of surfactant concentration 
favors the recovery percentages of IBP. 
When the TOA concentration was varied, the IBP 
transfer increases according to the TOA concentration. 
Permeability and Molar Flux values (see Table 2) are 
0.1939 cm.min-1 and 4.8 x 10-8 mol.cm-2.min-1 
respectively with a SLM with 1% w/V TOA + 1% w/V 
Abil EM 90 + Parleam 4, that represents the best 
performance vis-à-vis the IBP transfer.  
On the other hand, it is possible to observe that the 
Permeability and the Molar Flux values are higher for a 
stirring rate of 2000 rpm and 2000 rpm for feed and 
stripping phases, respectively. Figure 9 shows the IBP 
transfer at 2000 rpm as stirring rate for the both 
phases. It can see that the IBP can be recovered in 
about 90% after 10 hours of transfer time, and also the 
50% of IBP transferred is reached very fast, comparing 
it with the other conditions studied. Then the IBP 
transfer from the feed phase to the SLM and from the 
 
Figure 7: ln ([IBP]t / [IBP]t,0) variation during the IBP transfer by SLM. TOA concentration: a) 1 % w/V; b) 2 % w/V. Feed phase: 
[IBP] = 50 mg.L-1 dissolved in solution at pH 2, Stripping phase: phosphate buffer at pH 7. SLM: hydrophobic polyvinylidene 
difluoride support (PVDF) impregnated with TOA dissolved in dodecane. Transfer time: 10 hr, stirring rate: 1000 rpm for both 
phases. 
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SLM to the stripping phase is almost complete at these 
conditions. 
 
Figure 9: IBP transfer through SLM. Feed: [IBP] = 50 mg.L-1 
dissolved in solution at pH 2, Strip: phosphate buffer at pH 7. 
Stirring rate: Feed 2000 rpm, Strip 2000 rpm SLM: 
hydrophobic polyvinylidene difluoride support (PVDF) 
impregnated with 1% w/V TOA + 1% w/V Abil EM 90 + 
Parleam 4.  
Reactions involved in the mass transfer of IBP 
through the SLM 
Taking into account that the extraction process was 
carried out at acidic pH (~ 2), the molecules of TOA 
can solvate the non-charged form of ibuprofen, HIBP 
(pka 4.9) [44, 45] (see Figure 10), allowing the 
extraction of this one to the organic phase by a 




Figure 10: IBP predominance diagram as a function of pH. 
With respect to the stripping mechanism, the 
ibuprofen-amine complex is broken by the OH- ions 
contained into the stripping phase, hence transferred to 
the stripping phase. Both reactions are represented as 
follows: 
Extraction: TOA + HIBP ! TOA :HIBP  
Stripping: TOA :HIBP + OH ! " IBP! + TOA + H 2O  
Where, the species with the overbar represent those 
into the organic phase (SLM phase). 
CONCLUSIONS 
The recovery of IBP from acidic aqueous solutions 
has been performed with a SLM composed by Parleam 
4 (or dodecane) as diluent, tri-octylamine (TOA) like 
carrier and Abil EM 90 as surfactant. In the case of 
SLM without surfactant, the nature of stripping phase 
was evaluated, being the phosphate buffer slightly 
more efficient for the IBP mass transfer from feed 
phase to membrane and from this one to stripping 
phase at less time and able to regulate the pH value at 
7, which it is favorable for the IBP recovery. An efficient 
IBP transfer was reached without accumulation of drug 
on the SLM, when the stirring rate is higher of 1000 
rpm for the both phases. An IBP transfer almost 
complete (98 %) to stripping phase was reached after 
10 hours, and the SLM was stable during all this time. 
In the case of the SLM with surfactant, it was observed 
that for a 1% w/Vof Abil EM 90, the SLM had a good 
performance, with a Permeability of 0.1939 cm.min-1.  
The SLM needs very low quantities of solvent and 
extractant to recover almost the 98% of ibuprofen. This 
method is friendly with the environment and it can be 
Table 2: Permeability and Molar Flux of IBP for Several Values of TOA and Surfactant (Abil EM 90) Concentrations, at 
Different Stirring Rates. Feed: [IBP] = 50 mg.L-1 Dissolved in Solution at pH 2, Strip: Phosphate Buffer at pH 
7, SLM: Hydrophobic Polyvinylidene Difluoride Support (PVDF) Impregnated with TOA + Abil EM 90 + 
Parleam 4. Transfer Time: 5 hr 







0.5 1 2000 2000 0.1139 2.9 x 10-8 
1 1 2000 2000 0.1939 4.8 x 10-8 
1 0.5 2000 2000 0.1851 4.6 x 10-8 
1 0.1 2000 2000 0.1600 3.9 x 10-8 
1 1 1000 2000 0.1422 2.1 x 10-8 
1 1 2000 1000 0.1797 4.6 x 10-8 
1 1 2000 2000 0.1939 4.1 x 10-8 
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useful as secondary process during the wastewater 
treatment.  
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